Inventor · disambiguated record
Ronald Barbaras
Also filed as: BARBARAS RONALD
7 granted patents·12 pending applications·14 citations·filing 2002–2025
81Inventor score
Files withCERENIS THERAPEUTICS HOLDING SA8ABIONYX PHARMA SA6INST NAT SANTE RECH MED2CERENIS THERAPEUTICS S A & NIPPON CHEMIPHAR CO LTD1TUPIN CYRILLE1
Top patents by PatentIndex Score
19 records- 0184US11752163B2CER-001 therapy for treating kidney diseaseABIONYX PHARMA SA·Filed 2021·Granted Sep 12, 2023·2 cites·13 claims
- 0281US8349833B2Compounds, compositions and methods useful for cholesterol mobilisationCERENIS THERAPEUTICS HOLDING SA·Filed 2011·Granted Jan 8, 2013·7 cites·8 claims
- 0379US9085585B2Compounds, compositions and methods useful for cholesterol mobilizationCERENIS THERAPEUTICS HOLDING SA·Filed 2012·Granted Jul 21, 2015·3 cites·11 claims
- 0475US12364705B2CER-001 therapy for treating kidney diseaseABIONYX PHARMA SA·Filed 2023·Granted Jul 22, 2025·0 cites·29 claims
- 0575US9757381B2Compounds, compositions and methods useful for cholesterol mobilizationCERENIS THERAPEUTICS HOLDING SA·Filed 2016·Granted Sep 12, 2017·1 cites·16 claims
- 0672US2025312366A1Cer-001 therapy for treating kidney diseaseABIONYX PHARMA SA·Filed 2025·Application pending·0 cites
- 0769US9713619B2Compounds, compositions and methods useful for cholesterol mobilizationCERENIS THERAPEUTICS HOLDING SA·Filed 2015·Granted Jul 25, 2017·1 cites·9 claims
- 0862US10220040B2Compounds, compositions and methods useful for cholesterol mobilizationCERENIS THERAPEUTICS HOLDING SA·Filed 2017·Granted Mar 5, 2019·0 cites·27 claims
- 0960US2020061072A1Compounds, compositions and methods useful for cholesterol mobilizationCERENIS THERAPEUTICS HOLDING SA·Filed 2019·Application pending·0 cites
- 1054US2024215570A1Use of lipid binding protein-based complexes in organ preservation solutionsABIONYX PHARMA SA·Filed 2022·Application pending·0 cites
- 1153US2025255931A1Methods for treating leukocytosis, endothelial dysfunction and carditis using lipid binding protein-based complexesABIONYX PHARMA SA·Filed 2023·Application pending·0 cites
- 1252US2018203025A1Hdl therapy markersCERENIS THERAPEUTICS HOLDING SA·Filed 2018·Application pending·0 cites
- 1351US2025360184A1Methods for treating acute conditions using lipid binding protein-based complexesTUPIN CYRILLE·Filed 2023·Application pending·0 cites
- 1450US2015316566A1Hdl therapy markersCERENIS THERAPEUTICS HOLDING SA·Filed 2015·Application pending·0 cites
- 1546US2024033322A1Methods for treating acute conditions using lipid binding protein-based complexesABIONYX PHARMA SA·Filed 2021·Application pending·0 cites
- 1641US2006246520A1Gamma delta t cell-mediated therapyINST NAT SANTE RECH MED·Filed 2004·Application pending·0 cites
- 1735US2011092517A1Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related DiseasesCERENIS THERAPEUTICS S A & NIPPON CHEMIPHAR CO LTD·Filed 2010·Application pending·0 cites
- 1831US2007249555A1Use of Atp Analogues for Treatment of Cardiovascular DiseasesINST NAT SANTE RECH MED·Filed 2005·Application pending·0 cites
- 1929US2004072368A1Lipoprotein receptorFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →